Inflammatory lung diseases are characterized by chronic inflammation and oxidant/antioxidant
imbalance, a major cause of cell damage. The development of an oxidant/antioxidant …

The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …

Air pollution is increasingly recognized as an important and modifiable determinant of
cardiovascular disease in urban communities. Acute exposure has been linked to a range of …

Background The Standards for the Diagnosis and Treatment of Patients with COPD
document 2004 updates the position papers on chronic obstructive pulmonary disease (COPD) …

Epidemiological studies have consistently shown an association between particulate air
pollution and not only exacerbations of illness in people with respiratory disease but also rises …

Carbon nanotubes 1 have distinctive characteristics 2 , but their needle-like fibre shape has
been compared to asbestos 3 , raising concerns that widespread use of carbon nanotubes …

Significant heterogeneity of clinical presentation and disease progression exists within
chronic obstructive pulmonary disease (COPD). Although FEV 1 inadequately describes this …

Experimental studies have shown that rats exposed to ultrafine particles of, for example,
titanium dioxide or carbon black, sustain more lung injury and pathology than rats exposed to …

Studies into the effects of ultrafine particles in the lung have shown adverse effects considered
to be due in part to the particle size. Air pollution particles (PM 10 ) are associated with …

Background Chronic obstructive pulmonary disease (COPD) is a complex condition with
pulmonary and extra-pulmonary manifestations. This study describes the heterogeneity of …